Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View
Сергей Вячеславович Семочкин
Abstract:In 2022, the hematological community was faced with a rather non-trivial event of simultaneous publication of two competitive classifications of hematopoietic and lymphoid tumors drawn up by different teams of the international leading experts. During the last 20 years, the generally recognized standard used for diagnosis was provided by several consecutive editions of classifications of hematological neoplasms published by the World Health Organization (WHO) in 2001, 2008, and 2016. Since the 4th edition of t… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.